| scholarly article | Q13442814 |
| P2093 | author name string | R Williams | |
| D B Evans | |||
| K Rolles | |||
| D J White | |||
| R Y Calne | |||
| S Thiru | |||
| P McMaster | |||
| T J Duffy | |||
| B R MacDougall | |||
| R G Henderson | |||
| D V Hamilton | |||
| P2860 | cites work | Cyclosporin A in patients receiving renal allografts from cadaver donors | Q34347891 |
| The use of cyclosporin A and prednisone in cadaver kidney transplantation | Q37305573 | ||
| A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man | Q39220262 | ||
| Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers | Q39574059 | ||
| Prolamine solution to block pancreatic duct | Q66704894 | ||
| Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report | Q72132257 | ||
| Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation | Q72419264 | ||
| Two cases of benign lumps after treatment with cyclosporin A | Q72434228 | ||
| P433 | issue | 6268 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| organ transplantation | Q69253852 | ||
| P304 | page(s) | 934-936 | |
| P577 | publication date | 1981-03-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Cyclosporin A in cadaveric organ transplantation | |
| P478 | volume | 282 |
| Q42408980 | 99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. |
| Q73384066 | A novel nitric oxide scavenger in combination with cyclosporine A ameliorates experimental autoimmune encephalomyelitis progression in mice |
| Q41729913 | Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3) |
| Q37310997 | Cadaveric renal transplantation under cyclosporine-steroid therapy |
| Q46387294 | Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes |
| Q70804117 | Cosmas and Damian in the 20th Century? |
| Q40131054 | Cyclosporin A - Usefulness, Risks and Mechanism of Action |
| Q34396812 | Cyclosporin A and Kidney Transplantation: Present Status of a Partially Randomized Trial |
| Q72482806 | Cyclosporin A immunosuppression and Epstein-Barr antibody |
| Q40246910 | Cyclosporin A. Clinical pharmacology and therapeutic potential |
| Q67898887 | Cyclosporin a regulates the expression of HLA-DR on human monocytes by two different mechanisms |
| Q70302612 | Cyclosporin a: Pharmacologic activity on the immune system and effects in clinical organ transplantation |
| Q39558964 | Cyclosporin and renal graft histology |
| Q42212477 | Cyclosporine-pancuronium interaction in a patient with a renal allograft |
| Q70318562 | Cyclosporine. Kidney transplantation |
| Q70309967 | Cyclosporine: Five Years' Experience in Cadaveric Renal Transplantation |
| Q35675934 | Cyclosporine: a review |
| Q40200051 | Cyclosporine: immunology, toxicity and pharmacology in experimental animals |
| Q41352078 | Cyclosporine: progress, problems, and perspectives. |
| Q70357983 | Diabetic nephropathy |
| Q43936996 | Direct action of cyclosporin A on human B-lymphocytes with regard to immunoglobulin production |
| Q33912886 | Effect of cyclosporin A on murine natural killer cells |
| Q68016655 | Effect of cyclosporins A, G, and H on normal and ichthyotic keratinocyte growth in culture |
| Q36633160 | Epstein-Barr virus and human diseases: recent advances in diagnosis |
| Q34275840 | Evolution of liver transplantation |
| Q70386814 | Experience with cyclosporine and steroids in clinical renal transplantation |
| Q42121630 | Experimental cyclosporin A nephrotoxicity. |
| Q40150649 | Immunobiological determinants in organ transplantation |
| Q71012923 | Immunologic insights into uveitis and retinitis: the immunoregulatory circuit |
| Q57704867 | Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity |
| Q74059983 | Influences of immunosuppressive agents, FK506 and cyclosporin on systemic Candida albicans infection in mice |
| Q41560578 | Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat. |
| Q44812476 | Learning and new discovery with cyclosporine in the Cambridge-King's Programme: a personal view |
| Q34561587 | Liver and kidney transplantation in children receiving cyclosporin A and steroids |
| Q42359396 | Liver transplantation comes of age. |
| Q70243583 | Liver transplantation for liver cancer |
| Q41016665 | Liver transplantation. The last ten years. |
| Q34101719 | Liver transplantation: current concepts |
| Q38525332 | Living related renal transplantation in Ireland: a sixteen year review |
| Q33653150 | Neonatal administration of prolactin antiserum alters the developmental pattern of T- and B-lymphocytes in the thymus and spleen of BALB/c female mice |
| Q72477823 | Nephrotoxicity of cyclosporin A in bone-marrow transplantation |
| Q41930734 | Nephrotoxicity of cyclosporine in liver transplantation |
| Q37781449 | Novel Strategies for Immune Monitoring in Kidney Transplant Recipients |
| Q41306081 | Pancreatic society of great britain and ireland: annual meeting, 1980: second scientific session. |
| Q34275886 | Past and future prospects of orthoptic liver transplantation |
| Q70190630 | Potential role of cyclosporin A in corneal grafting |
| Q72118345 | Pre-transplantation assessment of renal viability with 31P magnetic resonance spectroscopy |
| Q72477811 | Primary biliary cirrhosis: experience in a non-referral centre |
| Q52873615 | Prognostically controlled comparison of dialysis and renal transplantation. |
| Q70221801 | Prolactin receptors on human lymphocytes and their modulation by cyclosporine |
| Q42614864 | Renal and hepatic function in rats treated with cyclosporin A in combination with gentamicin or cephalosporin antibiotics |
| Q34497811 | Steps in immunosuppression for renal transplantation |
| Q38536674 | Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. |
| Q72471524 | The effect of long-term cyclosporin A on renal function |
| Q50899152 | The influence of cyclosporin A on the vascular permeability of the pancreatic islets and on diabetes induced by multiple low doses of streptozotocin in the mouse. |
| Q42614486 | The toxic effects of combined administration of cyclosporin A and gentamicin. |
| Q57651394 | The use of cyclosporin A in clinical organ grafting |
| Q35710888 | The use of cyclosporine in renal transplantation |
| Q79819453 | Use of cyclosporine in renal transplantation |
| Q37311411 | Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids |
| Q42336886 | What has happened to charity? |
| Q71455659 | [Steroid-free treatment of renal transplant patients with cyclosporin A. A European multicentre study] |
Search more.